Valued at USD 24.50 billion in 2024, the market is projected to reach USD 26.53 billion in 2025 and expand further to USD 51.45 billion by 2035, reflecting a compound annual growth rate (CAGR) of 6.8% over the forecast period. This growth is fueled by the emotional and entertainment companionship pets like dogs and cats provide, prompting owners to invest substantially in their health and wellness.

Market Drivers

Key factors propelling the market include:

- Rising pet ownership and the humanization of pets, leading to increased spending on animal nutrition, therapeutics, and veterinary services.
- Growing concern over zoonotic diseases, which has intensified demand for advanced diagnostics, treatments, and preventive care.
- Increasing disposable incomes and the expansion of pet health insurance, particularly in regions like North America and Europe.
- Strategic initiatives by industry players to develop innovative diagnostic technologies and pharmaceutical products.
- Government and institutional support for animal health research, exemplified by the European Partnership for Animal Health and Welfare, which involves significant investment to combat infectious diseases in animals.

Market Segmentation

The companion animal health market is segmented by type of animal, product, health concern, distribution channel, end user, and geography:

- By Type of Animal: Dogs dominate the market with a 46% share, reflecting their status as the most common pets and the strong emotional bonds they share with owners. Cats are expected to register a higher CAGR due to rising urban adoption and increased spending on specialized health care and nutrition. Other segments include avian, equine, and other animals.

- By Type of Product: Pharmaceuticals hold the largest market share at 42%, driven by demand for drugs addressing infectious and chronic diseases. Vaccines also represent a substantial portion due to their role in preventing infectious diseases. Veterinary services, including preventive care, diagnostics, dental care, and emergency services, are anticipated to grow at the highest CAGR, reflecting increased expenditure on comprehensive pet care.

- By Type of Health Concern: Infectious diseases currently account for the largest share, owing to concerns over zoonotic and infectious conditions. Nutritional disorders are expected to grow rapidly as awareness of pet nutrition’s role in overall health increases.

- By Distribution Channel: Hospital pharmacies lead with a 47% share, benefiting from the availability of tailored pharmaceutical products and professional guidance. However, e-commerce is projected to grow fastest due to convenience, wider product availability, and cost-effectiveness.

- By End User: Veterinary hospitals and clinics dominate with over 80% market share, supported by advanced healthcare infrastructure and professional veterinary services. Home care settings are expected to grow rapidly, driven by point-of-care diagnostics and remote treatment technologies.

- By Geography: North America holds the largest share (39%), supported by high pet adoption rates and advanced veterinary care, including widespread pet health insurance coverage. Europe also has a significant market presence, with high pet populations and insurance adoption in countries like Sweden and the UK. Asia-Pacific is forecasted to experience the fastest growth, fueled by government initiatives, rising pet ownership, and affordable vaccine development.

Market Challenges

Challenges restraining market growth include:

- High costs associated with veterinary care, limiting access for some pet owners.
- Inconsistent availability of veterinary medical facilities, especially in low- and middle-income countries.
- Regulatory complexities in approving new therapeutic products.
- Lack of reimbursement policies for veterinary care in many regions, which may hinder adoption of advanced healthcare services.

Emerging Trends

The companion animal health industry is undergoing transformative changes driven by:

- Technological innovations such as wearable devices for real-time health monitoring and AI-powered diagnostics, which improve accuracy and reduce costs.
- Development of functional feeds enriched with nutritional additives like probiotics and prebiotics to maintain optimal pet health.
- Integration of artificial intelligence in veterinary diagnostics and clinic operations, enhancing treatment precision and efficiency. For example, in January 2025, STELLAI launched a smart dog collar equipped with sensors to monitor pet health remotely.

Key Players

Leading companies active in the companion animal health market include Agrolabo, Boehringer Ingelheim International, Bayer, Ceva Animal Health, Dechra Pharmaceuticals, Elanco Animal Health, Heska, IDEXX Laboratories, Merck, Neogen, Norbrook, Ourofino Saúde Animal, Phibro Animal Health, Virbac, Vetoquinol, and Zoetis. These players are investing in research and development, strategic partnerships, and product innovation to maintain competitive advantage.

Recent Developments

Notable recent initiatives include:

- In September 2024, Calviri launched a trial for a therapeutic cancer vaccine targeting early-stage hemangiosarcoma in dogs.
- Boehringer Ingelheim acquired Saiba Animal Health to strengthen its pet therapeutics pipeline.
- DSM-Firemenich opened a new animal nutrition premix and additives manufacturing plant in Egypt, enhancing regional production capabilities.

Conclusion

The companion animal health market is poised for robust growth through 2035, driven by rising pet ownership, technological advancements, and increased investment in animal health. While challenges such as cost and regulatory hurdles remain, ongoing innovation and expanding veterinary services offer promising opportunities for industry stakeholders. The market’s evolution will be shaped by a combination of advanced therapeutics, preventive care, and digital health technologies, ensuring improved health outcomes for companion animals worldwide.

Thank you for reading Roots Analysis report. Kindly get in touch with Roots’ team to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services across industries. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, and venture and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.

Contact Details

Roots Analysis

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com/